Cytokine release syndrome

• Clinical translation and landscape of superparamagnetic iron oxide nanoparticles

  2025 Advanced Drug Delivery Reviews review Engineering Characterization and Applications of Magnetic Nanoparticles Open access

  28

  citations
• A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma

  2025 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

  25

  citations
• Nurses’ reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMT

  2024 Clinical Hematology International article Medicine CAR-T cell therapy research Open access

  3

  citations
• Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

  2024 European Journal of Heart Failure article Medicine Cancer Immunotherapy and Biomarkers Open access

  89

  citations
• Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells

  2024 Cell stem cell article Engineering 3D Printing in Biomedical Research Open access

  115

  citations
• Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab

  2024 Clinical Lymphoma Myeloma & Leukemia article Medicine Multiple Myeloma Research and Treatments Open access

  49

  citations
• A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors

  2023 Cancer Immunology Research article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent

  42

  citations
• Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

  2023 Blood article Medicine CAR-T cell therapy research Open access cited by 1 patent

  355

  citations
• An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA

  2023 HemaSphere article Medicine CAR-T cell therapy research Open access

  59

  citations
• A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies

  2023 Cell Reports Medicine article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 1 patent

  37

  citations
• Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

  2021 Cancers article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 28 patents

  171

  citations

11 results